Career Development Program
Career Development Program
批准号:
8094360
负责人:
Harvey R. Herschman
金额:
$19.1万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-09-15 至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The future of prostate cancer research lies in the continued creation and development of translational
projects and innovative investigators at major research institutions, as well as an institutional commitment to
support outstanding, dedicated scientists in the field. In order for new physician-scientists to grow and
flourish, funding support and peer mentorship is imperative to this process. The SPORE Career
Development Program will provide this research support and mentoring resource, allowing junior faculty to
transition to independent investigator status with adequate peer-reviewed funding. Career Development
Program funds will be designated to prepare investigators for careers in translational prostate cancer
research. In addition, in well-justified selected cases, mid-level and senior investigators who are already
established in another area of research will be eligible for support to re-direct their research focus to prostate
cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Organization and Administration
-
批准号:7991414
-
项目类别:
-
资助金额:$10.43万
-
财政年份:2010
-
负责人:Harvey R. Herschman
-
依托单位:
Career Development
-
批准号:7991464
-
项目类别:
-
资助金额:$9.64万
-
财政年份:2010
-
负责人:Harvey R. Herschman
-
依托单位:
Developmental Funds
-
批准号:7991463
-
项目类别:
-
资助金额:$19.02万
-
财政年份:2010
-
负责人:Harvey R. Herschman
-
依托单位:
Transductionally Redirected and Transcriptionally Restricted Adenovirus Therapy..
-
批准号:7991423
-
项目类别:
-
资助金额:$15.44万
-
财政年份:2010
-
负责人:Harvey R. Herschman
-
依托单位:
Small Animal Imaging Shared Resource
-
批准号:7944612
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2009
-
负责人:Harvey R. Herschman
-
依托单位:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
-
批准号:7804210
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2009
-
负责人:Harvey R. Herschman
-
依托单位:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
-
批准号:8105087
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2007
-
负责人:Harvey R. Herschman
-
依托单位:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
-
批准号:7633349
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Harvey R. Herschman
-
依托单位:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
-
批准号:7458647
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Harvey R. Herschman
-
依托单位:
Career Development Program
-
批准号:7315101
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2007
-
负责人:Harvey R. Herschman
-
依托单位:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
-
批准号:7845543
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Harvey R. Herschman
-
依托单位:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
-
批准号:7256096
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Harvey R. Herschman
-
依托单位:
Transductionally Redirected /Transcriptionally Restricte
-
批准号:7039881
-
项目类别:
-
资助金额:$14.62万
-
财政年份:2005
-
负责人:Harvey R. Herschman
-
依托单位:
Core--Career development program
-
批准号:6930844
-
项目类别:
-
资助金额:$10.82万
-
财政年份:2005
-
负责人:Harvey R. Herschman
-
依托单位:
Developmental Funds
-
批准号:7090973
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2005
-
负责人:Harvey R. Herschman
-
依托单位:
Core--Cyclotron & radiochemistry facility
-
批准号:6930841
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2005
-
负责人:Harvey R. Herschman
-
依托单位:
Career Development Program
-
批准号:8291331
-
项目类别:
-
资助金额:$18.14万
-
财政年份:2002
-
负责人:Harvey R. Herschman
-
依托单位:
Career Development Program
-
批准号:7879468
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2002
-
负责人:Harvey R. Herschman
-
依托单位:
Career Development Program
-
批准号:7679548
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2002
-
负责人:Harvey R. Herschman
-
依托单位:
THE UCLA CENTER FOR IN VIVO IMAGING IN CANCER BIOLOGY
-
批准号:6132568
-
项目类别:
-
资助金额:$184.95万
-
财政年份:2000
-
负责人:Harvey R. Herschman
-
依托单位:
国内基金
海外基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
-
批准号:32070202
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:汪泉
-
依托单位:
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
-
批准号:--
-
项目类别:--
-
资助金额:40万元
-
批准年份:2020
-
负责人:Vikrant Gupta
-
依托单位: